Siddiqui, F., Tafur, A., Ramacciotti, L. S., Jeske, W., Hoppensteadt, D., Ramacciotti, E., . . . Fareed, J. (2019). Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values. Clin Appl Thromb Hemost.
Citación estilo ChicagoSiddiqui, Fakiha, Alfonso Tafur, Lorenzo Storino Ramacciotti, Walter Jeske, Debra Hoppensteadt, Eduardo Ramacciotti, Omer Iqbal, y Jawed Fareed. "Reversal of Factor Xa Inhibitors By Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values." Clin Appl Thromb Hemost 2019.
Cita MLASiddiqui, Fakiha, et al. "Reversal of Factor Xa Inhibitors By Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values." Clin Appl Thromb Hemost 2019.
Precaución: Estas citas no son 100% exactas.